MSB 2.11% 97.0¢ mesoblast limited

The other possibilty is based on this statment..... "There is...

  1. 5,344 Posts.
    lightbulb Created with Sketch. 956
    The other possibilty is based on this statment..... "There is potential for Valeant to find another partner for the Mesoblast assets
    given the favourable clinical data to date, particularly in heart failure. we understand that Valeant sold most of the R&D programs acquired with its
    Biovail7 acquisition to other natural partners" My belief is they will not pass off the MSB applications if they really understand the potential of them and future ones for that matter .But its wait and see. All conditions and payments are locked in anyway, Another plus for the MSB board on closing loopholes in all their transactions. Cheers Vin
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.020(2.11%)
Mkt cap ! $1.078B
Open High Low Value Volume
94.5¢ 97.0¢ 94.0¢ $795.0K 834.5K

Buyers (Bids)

No. Vol. Price($)
26 58472 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 17958 6
View Market Depth
Last trade - 12.43pm 21/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.